Belgium agency tackles delays in responding to simple pharma queries
This article was originally published in SRA
Executive Summary
Belgium's Federal Agency for Medicines and Health Products, the FAMHP, is taking steps to reduce the huge delays that drug companies face in getting a response from the agency's call center to their simple questions, such as the status of an application and other queries related to product registration.